Inhibition of hemangioma development in a syngeneic mouse model correlates with bcl-2 suppression and the inhibition of Akt kinase activity

Hemangiomas - current therapeutic strategies

(2011) Peace Mabeta et al.   INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY

BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received

(2010) S-J Dawson et al.   BRITISH JOURNAL OF CANCER

A comparative study on the anti-angiogenic effects of DNA-damaging and cytoskeletal-disrupting agents

(2009) Peace Mabeta et al.   ANGIOGENESIS

Down-regulation of Bcl-2 and Akt induced by combination of photoactivated hypericin and genistein in human breast cancer cells

(2009) Peter Ferenc et al.   JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY

Endothelial cells expressing Bcl-2 promotes tumor metastasis by enhancing tumor angiogenesis, blood vessel leakiness and tumor invasion

(2008) Pawan Kumar et al.   LABORATORY INVESTIGATION

Proliferation hemangiomas formation through dual mechanism of vascular endothelial growth factor mediated endothelial progenitor cells proliferation and mobilization through matrix metalloproteinases 9

(2007) Guo-You Zhang et al.   MEDICAL HYPOTHESES

Melittin induces Bcl-2 and caspase-3-dependent apoptosis through downregulation of Akt phosphorylation in human leukemic U937 cells

(2007) Dong-Oh Moon et al.   TOXICON